Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconINSMInsmed$31.72bnn/an/a
us flag iconIQVIqvia Holdings$28.31bn19.11n/a
us flag iconBNTXBioNTech SE$25.46bnn/an/a
us flag iconEXASExact Sciences$19.70bnn/an/a
us flag iconRVMDRevolution Medicines$18.62bnn/an/a
us flag iconRGCRegencell Bioscience Holdings$15.44bnn/an/a
us flag iconASNDAscendis Pharma A/S$13.35bnn/an/a
us flag iconIONSIonis Pharmaceuticals$13.06bnn/an/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconMEDPMedpace Holdings$12.15bn28.02n/a
us flag iconEXELExelixis$11.41bn15.48n/a
us flag iconSMMTSummit Therapeutics$11.14bnn/an/a
us flag iconMDGLMadrigal Pharmaceuticals$10.55bnn/an/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconTECHBIO-TECHNE$9.38bn510.53%
us flag iconTEMTempus AI$9.24bnn/an/a
us flag iconARWRArrowhead Pharmaceuticals$8.94bn41.42n/a
us flag iconIMGNImmunoGen$8.72bnn/an/a
us flag iconPRAXPraxis Precision Medicines$8.69bnn/an/a